Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) Trading 5.9% Higher

Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) shares shot up 5.9% during mid-day trading on Monday . The company traded as high as $27.75 and last traded at $27.68. 36,894 shares traded hands during mid-day trading, an increase of 149% from the average session volume of 14,833 shares. The stock had previously closed at $26.14.

The company has a fifty day moving average price of $26.11 and a two-hundred day moving average price of $24.42.

Featured Story: What is included in the gross domestic product?

Receive News & Ratings for Loncar Cancer Immunotherapy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loncar Cancer Immunotherapy ETF and related companies with MarketBeat.com's FREE daily email newsletter.